Pfizer has been sued for infringing on patent technology for the COVID-19 mRNA vaccines, developed by Arbutus Biopharma.
The lawsuit asserts that the defendants “could not have accomplished the feat of creating and manufacturing a vaccine at a speed unprecedented in the history of medicine but for their use of Plaintiffs’ existing and proven LNP technologies.”
“Yet Defendants never paid Plaintiffs to use those technologies. And Defendants continue to knowingly use the technologies to make and sell the vaccine, amassing tens of billions of dollars in revenue,” the suit continued. “Plaintiffs have thus filed this case to obtain fair compensation for their inventions, without which the vaccine would not exist.”
Reporting from The Epoch Times:
Arbutus and Genevant notified Pfizer and BioNTech in November 2020, before the vaccine was authorized by any country, that selling or offering to sell the vaccine may infringe on one or more patents and “offered to discuss the terms of a collaboration and/or license to further the parties’ goal of ending the COVID-19 pandemic,” according to the suit. ... With no word coming, Arbutus and Genevant sent a fresh notification of possible patent infringement on Oct. 12, 2021, and another letter last year expanding the infringement claims.
